IL-1β disrupts tendon homeostasis by driving inflammation and ECM degradation. LED therapy at 625 nm/52.8 J/cm2 mitigates these effects, potentially by restoring STAT3 activity within the IL-6/STAT3 axis, thereby suppressing IL-6 expression.This provides a mechanistic foundation for refining LED-based tendinopathy treatments.
Xia et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: